China Deal Monitor: Intel Capital leads $14m Series B round in KFBIO and more updates

Ningbo-headquartered biotech company Konfoong Biotech International Co.,Ltd (KFBIO) has  announced the completion of as much as 100 million yuan ($14 million) in its Series B round of financing, per a company statement on Thursday. It was led by Intel Capital, an investment vehicle of Intel Corporation focused on emerging technology companies globally.